Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Xiangjin Chen"'
Publikováno v:
Updates in Surgery. 74:735-746
Follicular thyroid carcinoma (FTC) is an indolent carcinoma. The cumulative incidence of death from patients with FTC and the nomogram built based on the competing risks model have not been described. The data from patients diagnosed with primary FTC
Publikováno v:
Endocrine Connections, Vol 10, Iss 6, Pp 656-666 (2021)
Endocrine Connections
Endocrine Connections
Background The presence of clinically negative nodules on the contralateral lobe is common in patients with unilateral papillary thyroid microcarcinoma (PTMC). The appropriate operational strategies of contralateral thyroid nodules remain controversi
Autor:
Youzhi Zhu, Junyu Lin, Xiangjin Chen, Ke Zheng, Yixing Yan, Huihao Zhang, Lingjun Kong, Ling Chen, Kunlin Wu
Publikováno v:
Journal of Surgical Oncology. 123:1521-1528
BACKGROUND AND OBJECTIVES Although the significance of Delphian lymph nodes (DLNs) in patients with papillary thyroid carcinoma (PTC) has been reported, all studies have been based on a small sample size and lack a direct statement concerning prognos
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundSalvage mastectomy (SM) is the standard surgery for ipsilateral breast tumour recurrence (IBTR). However, whether repeat breast-conserving surgery (RBCS) is an alternative method remains unclear. We performed a meta-analysis to compare the
Autor:
Yixing Yan, Xiaoyu Liu, Caiqin Mo, Ling Chen, Kunlin Wu, Xiangjin Chen, Junyu Lin, Youzhi Zhu, Huihao Zhang, Sunwang Xu
Publikováno v:
Cell Death Discovery
Cell Death Discovery, Vol 7, Iss 1, Pp 1-8 (2021)
Cell Death Discovery, Vol 7, Iss 1, Pp 1-8 (2021)
Papillary thyroid cancer (PTC) is the main histological type of thyroid cancer and accounts for almost all increased cases worldwide. Patients with PTC exhibit a favorable prognosis, but the fact that PTC is often accompanied by a high prevalence of
Publikováno v:
EURASIP Journal on Wireless Communications and Networking, Vol 2021, Iss 1, Pp 1-18 (2021)
Vehicular Ad-hoc Networks (VANETs) can improve the road safety by transmitting safety-critical messages such as beacons and emergency messages. IEEE 802.11p VANETs have adopted the carrier sense multiple access with collision avoidance (CSMA/CA) mech
Autor:
Shuyun Weng, Youzhi Zhu, Yao Lin, Yun Xia, Qingshui Wang, Xiangjin Chen, Xiaoxue Xiong, Junyu Lin, Yan Ye, Haitao Niu, Yajuan Chen, Ling Chen, Huizhen Ni
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Background Breast cancer is one of the most common tumors for women globally. Various miRNAs have been reported to play a crucial role in breast cancer, however the clinical significance of miR-1908-3p in breast cancer remains unclear. The present st
Autor:
Zhenying Chen, Weibing Miao, Fangmeng Fu, Shan Zheng, Chao Huang, Bing Jia, Xiangjin Chen, Fang Li, Zhaohui Zhu, Yinghong Yang
Publikováno v:
Molecular Imaging and Biology. 20:846-856
This study aimed to investigate the value of 99mtechnetium-three polyethylene glycol spacers-arginine-glycine-aspartic acid ([99mTc]3PRGD2) imaging in diagnosis and staging of breast cancer compared with 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) ima
Autor:
Xiangjin Chen, Lingjun Kong, Youzhi Zhu, Zongcai Wang, Ke Zheng, Jiajie Xue, Huihao Zhang, Kunlin Wu, Ling Chen, Mingji Ding
Publikováno v:
Tumor Biology. 37:8037-8045
This study aims to evaluate the difference of central lymph node metastases (LNM) in papillary thyroid carcinoma (PTC) associated with or without Hashimoto's thyroiditis (HT) in predicting lateral node metastasis. A retrospective case control study w
Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer
Autor:
Qinghai Ji, Zhendong Li, Zhuming Guo, Jun Wang, Jinwan Wang, Feng Du, Xiangjin Chen, Pingzhang Tang, Ming Gao, Yuan Zhang, Yongkun Sun, Yihebali Chi
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 28(11)
The prognosis of advanced or metastatic medullary thyroid carcinoma (MTC) is poor, and there are few therapeutic options. Anlotinib has previously shown promising antitumor activity on MTC in preclinical models and a Phase I study. This Phase II clin